Your browser doesn't support javascript.
loading
Primary non-Hodgkin,s lymphoma of the uterine cervix.
Article in English | IMSEAR | ID: sea-37747
ABSTRACT
Primary malignant lymphoma of the cervix is a rare disease. Because the number of reports of this cancer is limited, there is no consensus on its management, prognosis or the efficacy of various treatments. Primary malignant lymphoma of the cervix stage Ib was diagnosed in a 25-year-old woman. The patient was treated with 6 courses of CHOP chemotherapy (cyclophosphamide, doxorubicin, vincristine, and prednisone). Clinical and pathological responses were complete. This case supports current thinking in that, in selected young patients with primary malignant lymphoma of the cervix who desire to preserve fertility and ovarian functions, combination chemotherapy regimens such as CHOP are the treatment of choice.
Subject(s)
Full text: Available Index: IMSEAR (South-East Asia) Main subject: Vincristine / Lymphoma, Non-Hodgkin / Female / Humans / Prednisone / Antineoplastic Combined Chemotherapy Protocols / Doxorubicin / Uterine Cervical Neoplasms / Adult / Cyclophosphamide Type of study: Prognostic study Language: English Year: 2008 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: IMSEAR (South-East Asia) Main subject: Vincristine / Lymphoma, Non-Hodgkin / Female / Humans / Prednisone / Antineoplastic Combined Chemotherapy Protocols / Doxorubicin / Uterine Cervical Neoplasms / Adult / Cyclophosphamide Type of study: Prognostic study Language: English Year: 2008 Type: Article